Daily Archives: February 10, 2007

Forward P/E Distortions: The Case of Amazon

Posted on Feb 11th, 2007 with stocks: AMZN ATHR ELOS

CrossProfit submits: Pursuant to a previous article here is another example, Amazon. Though one should not compare apples with oranges as there are major differences between Atheros (ATHR) and Amazon (AMZN), both have fallen victim to the Forward P/E Distortion Syndrome.

The current quarter for both AMZN and ATHR ends in March 2007. Trailing twelve months (ttm) PE conventionally refers to the last reported period, going back 12 months. This is the earnings for 2006. Forward PE conventionally refers to the following 12 months. This is the earnings for 2007.

Many computer programs have a ‘bug’ in them. In a nut shell, because we are now in 2007, programs erroneously take 2008 as the following 12 months. In most cases, 2008 figures are analyst estimates without the foundation of company guidance. More often than not, these figures change substantially, both up and down, over the pursuing six months. For some reason once the first quarter of 2007 is reported the programs correct themselves and calculate forward PE correctly; meaning Q2 2007 through Q1 2008.

Take a look at the Yahoo! Finance figures here and here.

You will notice the following;

1) Current year average EPS estimates (2007) are at 0.67. This is what ‘Forward PE’ should be calculated on.

2) Next year EPS is 0.92. 2008 is not a true basis for forward PE as 24 months out is inherently unreliable.

3) Under the “Delayed quote data” heading you have ttm EPS listed as 0.45 and a ttm PE of 86.43. This is not a typo, this is correct. Amazon is trading at a PE of over 80!

4) Yahoo! Finance lists the Forward P/E (1yr) as 42.09! This is incorrect. As mentioned above, the computer program has taken the closing price of 38.72 and divided by the 2008 figure of 0.92 resulting in a forward PE of 42.09. The correct calculation should be; 38.72 divided by 0.67 = 57.8.

Summary: The current price of an Amazon share is at 86 times ttm earnings and at 57 times forward 1 year projected earnings and at 42 times the earnings guestimate in two years from now.

Apples, Oranges and Peaches

Another way of looking at this is that due to the forward PE being artificially lowered as a result of incorrect information, the market may not realize that it is pricing ATHR and AMZN too high based on what would have been reasonable expectations, at least in the case for ATHR.

In the case of ATHR, both revenue and profit will increase in line with guidance. Yes, that means in line with 2007 guidance – NOT 2008 (there is no official guidance for 2008). Unless ATHR has a blow-out quarter in Q1 2007, this stock will crash when it reports earnings for Q1. Then we get stuck in a ‘once burnt twice cautious’ mode and when the stock should eventually appreciate in value, it lags.

Just last year the same happened to Syneron Medical (ELOS). In Q4 2005 the market got ahead of itself and priced ELOS in the 40’s – peachy indeed! When the stock obviously couldn’t meet those types of expectations, the market punished the stock for 6 months all the way down to 18. Finally the stock rebounded to a normal range of around 26. Now it can grow in a normal fashion.

We have to wait for the execution of Q1 to determine if ATHR should be trading above 24. In fact it shouldn’t be above 23 right now. Currently the market has assigned a value as if ATHR already reported EPS at 0.25 for Q1 2007. This is unlikely to happen for several reasons – not within the scope of this article. We like ATHR, and are long term long on this company. [Disclosure: some associates own ATHR based on our research.] Logically, why should ATHR get ‘punished’ and have the stock drop to 16 or lower, in consequence of some misconception or other market shenanigans? At current multiples (ttm 75!), the slightest hiccup will send this stock down 50%. ATHR has some (manufacturing) hurdles to get over. At more reasonable multiples, time to recover is granted without panic setting in.

In the case of AMZN, the forward P/E distortion is compounded with unreasonable analyst expectations for 2007. The company’s own guidance says so! Be it suffice to say that as much as we like the concept around the hype – or is that the hype around the concept – AMZN is beginning to show its true colors a-propos being a money making machine. IT CAN’T DO IT.

Why do you think JB poured hundreds of millions of your Dollars into exploring other income avenues? Maybe if his initials were JC he could pull it off (referring to Jim Cramer, is there any other godly possibility?).  God has just done a ‘coin-flip’ again and is now negative on tech. G-d help us!

Notice the severe change in attitude at AMZN when high margin items are in jeopardy.

http://www.thestreet.com/_mktw/newsanalysis/techstockupdate/10337991.html

Right now AMZN has reached the point of diminishing returns. In plain English this means that in order to feed the market expectations, at least in revenue growth, it has to take on lower margin items. While maintaining 25% revenue growth, profit margins continue to decline. Eventually the company will start posting losses (again) and that is when we start the downsizing cycle or as some say ‘back to basics’. In contrast with ATHR, we have a long term bearish outlook on AMZN.

Fool’s Platter

Yesterday, the Motley Fool published an article that basically said the same thing but from a slightly different angle. Below is an excerpt.

    Legg Mason chief investment strategist Michael Mauboussin talks a lot about expectations. His ideas show me that there aren’t "cheap" or "expensive" stocks. Instead, there are three types of stocks:
    1. Stocks that meet the market’s expectations.
    2. Stocks that fall short of the market’s expectations.
    3. Stocks that exceed the market’s expectations.

    Suffice to say that we’d all like to fill our portfolios with stocks that exceed the expectations the market has priced into them…

    Thus, it can be much more advantageous to hold Company A, which grows earnings 5%, instead of Company B, which grows earnings 25%, if the market expected 3% growth from Company A and 30% growth from Company B. Heck, the biggest stock price bumps occur when results are better than the market expected …

    Consider these examples:

    Company

    Three-Year 
    Revenue Growth*

    Three-Year
    Return

    Micron Technology (NYSE: MU)

    15.7%

    (18.9%)

    Amazon.com (NASDAQ: AMZN)

    26.7%

    (14.7%)

    Novellus Systems (NASDAQ: NVLS)

    21.5%

    (5.5%)

    Denny’s (NASDAQ: DENN)

    2.7%

    599%

    Carolina Group (NYSE: CG)

    3.7%

    156%

    *Annualized. Data courtesy of Capital IQ …

    Why did impressive earnings growth translate into mediocre stock-price growth for Micron, Amazon, and Novellus? One answer, of course, is expectations. The market expected more from these companies than they could achieve. It clearly didn’t expect quite as much from Denny’s or Carolina Group — and these stocks have simply blown away the market’s expectations.

Conclusion

Be careful and do your own calculations for forward PE during the first quarter of every calendar year.

There is a major difference between a forward PE of 22 and 32. Atheros (ATHR) should be trading at a forward PE of 30 which is $24.00 per share. That’s because we are bullish on this stock, otherwise $21.00/$23.00 is reasonable. Remember, the current forward PE is not 22. A ‘run’ now on ATHR is to its intermediate term and perhaps long-term detriment.

Amazon (AMZN), adopting the bullish stance for the moment, should be trading around $28.15/$30.15, or between 42 to 45 times forward earnings. The most bullish analyst estimate puts 2007 earnings at 0.78. At 0.78 times 45, assuming a bullish growth rate as well, this gives a current value of $35.10. In our honest opinion, last year lows will eventually be taken out but only after AMZN reports for Q2 2007, demonstrating that there is no-way that this company will ever pluck $1B in a given year for the next five years. There is even a chance that AMZN can’t do it accumulatively. We couldn’t care less about a run on AMZN other than maybe shorting at 39+…the stock is headed south over the long term anyway so if it crashes it will just get there sooner.

All stocks that ‘run’ end up with a crash. There has never been an exception. When a company lends its treasury stock to a brokerage house to cover shorts, the run is for the company’s stock compensation program and brokers – not the investors. After the two have cashed-in, the stock crashes. This is the flip-side of the Overstock (OSTK) case. Naked shorts drive down the stock price. Covered shorts drive the price up. Nowadays investors do not write letters to the SEC. Instead, shareholders have found that class action is far more rewarding. We trust ATHR is not lending any stock.

Now compare the ttm + forward PE, projected revenue growth and earnings growth for AMZN, ATHR and ELOS and admit you like fruit cocktail! By the end of this week we should know which of the three is the choice produce for thee.

Multiple Break-Up Values From This Week

Stock Tickers: CL, NWS, TYC, C, MET, GLW, WM

This week 24/7 Wall St. featured many names that fall within the realmof larger private equity screens as far as potential break-up stocks.That does not mean that they WILL be broken apart or that the companiesare certain candidates, but this is one of many screens that firmsrun.  As with ANY 'value' or 'screen' there is a matter of opinion andnot everyone will share the same opinion.  We also have the methodology posted at the end.  Here is the first half of the list:

24/7 Wall St. break-up value for Colgate (CL): $70.00; stock price was $67.00 at the time.

24/7 Wall St. break-up value for News Corp (NWS): $25.00; stock price was $25.00 at the time.

We also ran a piece about how much of the perceived extra value in Tyco(TYC) was already starting to look like it was priced in ahead of thecompany earnings.

24/7 Wall St. break-up value for Citigroup (C): $65.00; stock price was $54.75 at the time.

24/7 Wall St. break-up value for Met Life (MET): $79.00; stock price was $63.00 at the time.

24/7 Wall St. break-up value for Corning (GLW): $35.00; stock price was $21.00 at the time.

24/7 Wall St. break-up value for Washington Mutual (WM): $59.00; stock price was $45.50 at the time

METHODOLOGY

This Week on StockHouse February 5 to February 9

Friday, February 9, 2007
By the StockHouse editorial team

The week began with a silver lining. Orko Silver (TSX: V.OK, BullBoards), a silver junior with a big land position in the Durango State in Mexico, was the featured firm in Danny Deadlock’s Micro-cap Monday column.

Further south, International PBX (TSX: V.PBX, BullBoards) holds some interesting copper properties in Chile. But the thing to watch, according to Resource Report senior editor Doug Hadfield, is the company’s Copaquire copper molybdenum project in northern Chile.

From rocks to rock ‘n roll – Digital Music licenses digital music recordings to online music stores like Apple’s (NASDAQ: AAPL, BullBoards) iTunes site. The company warranted a strong buy from Institutional Research Partners.

Investors who read Steven Saville’s latest column may be more cautious about their investments going forward. A forecast for reduced profits and less liquidity had the columnist forecasting a down year for U.S. stock markets.

But natural resources stocks are expected to push higher, according to Clif Droke.

In fact, fundamental and technical factors point to renewed gains for gold exchange traded funds, according to ETF Check columnist Don Vialoux.

In our list of lists, Solitare Minerals (TSX: V.SLT, BullBoards) was the latest junior uranium company to vault to the top of the BullBoards. For more on what users are talking about, check out this week’s StockHouse Top Five.

Among the list of company shenanigans identified by the Securities Sleuth, insiders at Nutrisystem (NASDAQ: NTRI, BullBoards) were selling late last year, and emerged unscathed after warning Q1 earnings would not meet expectations.

Jordan Kimmel, this week’s market wizard, liked the consumer confidence data, which gave him confidence that the bull market is simply digesting gains.

STANDUP Advice author John De Goey chimed in with a timely column in RRSP season about which questions you ought to be asking your financial advisor.

While contributing editor Nancy Zambell wrote about how to own real estate without qualifying for a mortgage. REITs were the subject of this week’s Financially Fit column.

And in Pure Energy, Mike Schaefer says there could be a civil war brewing within OPEC.


By viewing any material on or distributed by Stockgroup and its Information Providers you agree to both the following disclaimer, and the full disclaimer that can be viewed here.
Any holdings, theories, speculation or trades appearing anywhere on Stockgroup’s network of websites should not be relied upon for purposes of transacting securities or other investments, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. This applies to any material regardless of source, placement, presentation or reproduction. Any Information Providers to Stockgroup or employees of Stockgroup may from time to time have positions in the stocks or other entities mentioned anywhere on the StockHouse. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. Stockgroup and its contributors makes no guarantee as to the validity of any information, speculation, theories or research presented herein whether pertaining to the past, present or future. The Service and The Materials are provided by Stockgroup and other Information Providers on an "as is" basis, and Stockgroup and other Information Providers expressly disclaim any and all warranties, express or implied, including, without limitation, warranties of satisfactory quality and fitness for a particular purpose, with respect to the service or any materials and products. In no event shall Stockgroup and other Information Providers be liable for any direct, indirect, incidental, punitive, or consequential damages of any kind whatsoever with respect to The Service, The Materials, and The Products.
 

Friday’s Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

REXAHN PHARMACEUTICL [RXHN.OB] +18.18%
LPATH INC [LPTN.OB] +14.29%
NEURALSTEM INC [NRLS.OB] +8.60%
CELL GENESYS INC [CEGE] +7.85%
ORTHOLOGIC CP [OLGC] +7.64%

Diagnostic Substances

SCOLR PHARMA INC [DDD] +5.71%
AVIGEN INC [AVGN] +4.58%
THRESHOLD PHARMACEUT [THLD] +4.40%
SONUS PHARM INC [SNUS] +3.68%
AVANT IMMUNOTHERAP [AVAN] +3.60%

Drug Delivery

INSITE VISION INC [ISV] +6.62%
QUIGLEY CORP THE [QGLY] +3.27%
PETMED EXPRESS INC [PETS] +1.91%
NOVADEL PHARMA INC [NVD] +1.74%
DELCATH SYSTEMS INC [DCTH] +1.05%

Drug Manufacturers

EXEGENICS INC [EXEG.OB] +10.29%
GEOPHARMA INC [GORX] +4.71%
SIGA TECH INC [SIGA] +3.50%
NEUROCHEM INC [NRMX] +3.18%
AP PHARMA INC [APPA] +3.10%

Medical Appliances & Equipment

MEDIS TECH LTD [MDTL] +8.05%
MICROTEK MED HLDGS [MTMD] +5.09%
SPAN AMERICA MED S [SPAN] +5.08%
ESCALON MED CP [ESMC] +4.68%
ALLIED HEALTHCARE [AHPI] +4.12%

Medical Instruments & Supplies

MILESTONE SCIENTIFIC [MLSS.OB] +10.87%
TUTOGEN MEDICAL INC [TTG] +8.27%
EP MEDSYSTEMS INC [EPMD] +8.22%
PRO-DEX INC NEW [PDEX] +7.69%
BIOFORCE NANOSCIENCE [BFNH.OB] +6.59%

Medical Laboratories & Research

GENOMIC HEALTH, INC. [GHDX] +0.26%

http://www.biohealthinvestor.com/

Viacom: The Beating Will Continue Until Morale Improves

Late word from the New York Post, is that Viacom (VIA) flagship MTV will sack 500 poor souls, many of them executives. That would save the media company $250 million a year, but it still may not save the company’s share price.

A look at media company shares over the last year puts Viacom in the cellar. The company’s stock is down slightly over the last year. Time Warner (TWX), CBS (CBS), Disney (DIS), and News Corp (NWS) have all done much better.

Viacom king of all media Sumner Redstone has done little to unlock any value at the firm.

In the September 2006 quarter, Viacom’s revenue barely moved from the year before, $2.66 billion compared to $2.478 billion in 05. Net income dropped from $423 million to $357 million.

The company’s 10-Q indicates that the cable networks business grew faster than the company as a whole, up 10%. Revenue at Viacom’s film unit was up only 1%. And, while operating income at the networks rose 14%, the film unit had a loss.

But, MTV appears to be bearing most of the company’s cost cutting.

The real problem with the picture at Viacom is that Redstone and his hand-picked CEO Philippe Dauman can take costs out, they appear to have not a single clue about increasing the topline. The firm’s attempt to capture online revenue has been lame. Disney’s download deal with Apple and Time Warner’s attempt to resurrect AOL may not be home runs, but they are, at least, a start.

And, Redstone is rich and can afford to give the departed severance.

Douglas A. McIntyre can be reached at douglasamcintyre@247wallst.com. He does not own securities in companies that he writes about.

A Zune Phone, Another Bad Dream For Apple

According to TechCrunch, the odds that Microsoft (MSFT) is working on a phone version of its Zune multimedia player are high. The phone may be set up to run on a 4G network, perhaps the one that Sprint (S) is building.

Wall St. has mostly thumbed its nose at the Microsoft Zune. And, why not? It came to market five years after the iPod which has built a lead of about 70 million units sold. But, the cell phone on steroids handset market is a different story. The iPhone will not be out to June, and Microsoft may not be far behind. It is also likely that Nokia (NOK), Motorola (MOT) and Sony-Ericsson (SNE)(ERIC) have had a look at the Apple (AAPL) product while planning roadmaps for their own next generation phones.

And, therein lies Apple’s problem. It may well have very little lead on the competition with its new phone. Investors have driven the stock to a one month low of $83.25, after strong earnings briefly moved the stock to almost $98. Now, Apple is faced with tepid guidance, a wait of several months for the iPhone, and potential options backdating problems for Steve Jobs at both AAPL and Pixar.

The iPhone is a good idea, but, for the time being, that is all it is on Wall St.

Douglas A. McIntyre can be reached at douglasamcintyre@247wallst.com. He does not own securities in companies that he writes about.

Google Stubs It Toe On Old Media

Google’s (GOOG) start in radio ad sales has been inauspicious, to say the least. The company is getting the worst airtime, so-called remnant space, for its ad inventory auction process aimed at selling time on the thousands of radio stations around the US.

Surprising. Not really. The most popular shows like Imus on the most popular networks like CBS (CBS) are sold out, and at high rates. All radio advertisers are after the same thing. Hot shows in drive time, for 6 AM to 10 AM. Not much goes on in radio land during the day until people drive home, and then there is another jump in listening audience.

The big radio companies are not going to let Google have the best inventory. They can sell it themselves and keep 100% of the yield.

That naturally raises the issue of how well Google will do selling newspaper advertising space. The company mentions the initiative frequently. As the growth of its core search advertising business slows, the company wants to demonstrate that it has other avenues for collecting revenue.

But newspapers are not much different from radio. Their best inventory is typically sold out. Remnant advertising may not be attractive because it can force the newspaper to print more pages, a significant expense.

It is too much to say that Google’s foray into new media has died early. But, it does need oxygen.

Douglas A. McIntyre can be reached at douglasamcintyre@247wallst.com. He does not own securities in companies that he writes about.

The Week of Cramer (FEB 5 to 9, 2007)

This was an odd Cramer week, because he was in but only partially.  He did his back to school tour at University of Virgina and many of his Wall Street Confidential videos were pre-recorded.  That aside, Jim Cramer did have some things to say.

Cramer is still behind Cisco (CSCO) and he came up with a speculative basket for telecom stocks.

He also gave another speculative pick Friday evening in the seed and seed technology sectory called Landec (LNDC).

On Friday he noted that the upgrade in Semiconductors was ill-timed and he likes "Ag as the new oil."  Here are the full comments on that segment.

In one pre-recorded segment he was actually out in favor of Sarbanes-Oxley and panned most of the current IPO’s in the hopper.

Cramer also had a weekly SELL BLOCK where he featured many past picks, but not all are outright sell calls.  He noted Avon (AVP), Wells Fargo (WFC), Washington Mutual (WM), Abercrombie & Fitch (ANF), Circuit City (CC), Sears (SHLD).

Cramer also said that DST Systems (DST) is a potential buyout candidate.

He also outlined how Sears (SHLD) would benefit from the Fortress IPO, and late yesterday I issued a piece showing how many other non-hedge fund alternative investment vehicles are out that are publicly traded stocks as well.

Cramer was also discussing the implosion in the subprime lenders after the restatements from New Century and after HSBC warned about lower lending hurting them.  He was also dead straight by saying that investors should wait before buying because they would drop further.

Cramer interviewed Celgene’s (CELG) CEO Robert Hugin, and we all know Cramer has been a pro-Celgene picker.

Cramer panned Crocs (CROX) on a long-term basis but said you can actually still make money off it in the near-term.  Under Armour (UA) was the one that Cramer thinks could end up being the next Nike.

While Cramer did this on a pre-recorded basis, it was very interesting to hear him pan ETF’s.  I didn’t agree with the call one bit and think it was a bit targeted, but I have only been on CNBC once and he is on many times a day.

He also started out the week by commenting that he has a new tech exception that you can buy called Avnet (AVT), although it is interesting that it is a distributore more than a producer.  Here is the original list of TECH EXCEPTIONS he gave in January for 2007 when he panned the entire sector.

Jon C. Ogg
February 10, 2007

Best and Worst Performing Stocks Year to Date

From Ticker Sense

The tables below highlight the best and worst performing stocks in the Russell 3000 over the past 5 days, the past 3 months, and year to date.

1wk209

3mo209

Ytd209

http://www.tickersense.typepad.com/